In line with previous studies [15, 21, 25], we observed significant accumulation of CD4+FoxP3+ Tregs in breast tumors (13.4 ± 2.3%), compared with NT (2.9 ± 1.3%; Figure 6A and 6B). This evidence concerns the gene CD4 and breast neoplasm.